From too little genomic diversity to an overemphasis on rare diseases and oncology, here are three trends from the 35th J.P. Morgan Healthcare Conference that will continue to play out this year.

The slew of news from the JP Morgan Healthcare conference that started this morning started with a trio of takeover deals from Johnson & Johnson, Novartis, and MSD. J&J’s $2 billion play for ...

The JP Morgan healthcare conference has become one of the most important events in the industry calendar – each year one or two CEOs are under particular pressure to convince investors their ...

Relive this year’s J.P. Morgan Healthcare Conference with the STAT reporters who attended. Get a full rundown of the deals, data, and scuttlebutt and come away with the ideas and water-cooler ...

The JP Morgan Healthcare Conference, which is being held in San Francisco this year, has been much more active than last year. Among some of the top news at the conference were M&A deal ...